Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
about
New perspectives in occult hepatitis C virus infectionCellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons.Trace amounts of sporadically reappearing HCV RNA can cause infectionSubinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infectionA polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.Molecular and contextual markers of hepatitis C virus and drug abuse.Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infectionHepatitis C virus-specific immune responses in noninjecting drug users.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineTH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study.Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.Virus-Specific Cellular Response in Hepatitis C Virus Infection.Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.More rare birds, and the occasional swan.Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.Enhanced natural killer cell activity is found in exposed uninfected recipients of hepatitis C-contaminated blood.
P2860
Q22305491-79938B33-DECB-4D7C-8B61-5F98EE54A113Q26749249-CAA9F947-4E30-4385-805E-9B04DE4CCB9CQ33719577-FE79FDD9-7F21-4405-BDCA-F2C9D1C165D3Q33881052-0EACA867-DC8D-4373-B489-5289DAD5C342Q33944273-CDC10CF0-4C99-473F-AE0E-6150B418115CQ34336913-1FF06546-A39A-44A3-BF00-D9408149BF3AQ34764010-D27F4750-0076-43C8-AAF5-DC50418CD185Q34764025-E0FEAD57-7D12-4790-9307-355A84B34C9DQ34982096-3A14DFBD-7B1F-467F-9713-C7A5CA586A30Q35356926-A57817FB-7729-4F8B-8560-427B6B2DDABBQ35660841-6EAFE2DD-AADA-4505-BC1F-F759E6D7F9DAQ35940716-EF9871BD-B980-475A-90AC-8B908FC5A936Q36013764-BEAA5F2E-BDF3-46F9-A7FE-CC7C8B028F24Q36208809-6927CB17-FFCB-44E4-B287-C1C5DD15FA9FQ36717008-E3313690-A16F-4F26-9AC2-9F1C971B7F38Q36849397-E4796B19-2225-45C4-8C6D-9485D7564141Q37109539-7034A91F-53E6-4D58-9A27-041C685CCFF9Q37540482-4F268D4A-6BF7-48F1-A730-7E20599386AFQ38010203-E0784A65-69BB-47CA-849D-8968185AD65CQ38597605-358071FF-054F-444F-A9C0-56E393A6953BQ39285745-78AC3B46-7659-4529-9D21-B203AE1CD4E0Q40871560-CEB87996-FC44-4129-8B56-F515B95ACBDFQ40942638-027A26BF-BA7A-43A1-BA12-38111A62E192Q42262339-36F4D702-EBBB-4C66-900F-B941664B7DC3Q42990115-77512E2F-4516-41DC-8744-117E53E965F8Q43040462-6292517C-6FB8-4C40-BF59-A1B587E3543EQ43117957-13B0BDA3-CEB7-463B-89F6-BE2F6C56E1D8Q44873304-48D260C1-5654-4C30-BF35-8F78CBECFDD1Q47602670-DEA74238-BDA1-4EE2-AE49-9CA5CB42CB73
P2860
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@ast
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@en
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@nl
type
label
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@ast
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@en
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@nl
prefLabel
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@ast
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@en
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@nl
P2093
P2860
P1476
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
@en
P2093
D C Des Jarlais
M Zeremski
P2860
P356
10.1111/J.1365-2893.2008.01016.X
P50
P577
2008-07-17T00:00:00Z